MEG insider sells 89,967 shares via 10b5-1; ends with 316,637
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Montrose Environmental Group (MEG) reported insider transactions by its President & CEO and Director. On November 10–11, 2025, the insider exercised 44,983 and 44,984 stock options at $6.03 per share, then sold 39,799, 5,072, 112, and 44,984 shares at weighted average prices of $24.626, $25.617, $26.17, and $24.073, respectively. After these transactions, direct beneficial ownership was 316,637 shares. The trades were made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 89,967 shares ($2,195,850)
Net Sell
8 txns
Insider
Manthripragada Vijay
Role
President & CEO
Sold
89,967 shs ($2.20M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 44,984 | $0.00 | -- |
| Exercise | Common Stock | 44,984 | $6.03 | $271K |
| Sale | Common Stock | 44,984 | $24.073 | $1.08M |
| Exercise | Stock Option (Right to Buy) | 44,983 | $0.00 | -- |
| Exercise | Common Stock | 44,983 | $6.03 | $271K |
| Sale | Common Stock | 39,799 | $24.626 | $980K |
| Sale | Common Stock | 5,072 | $25.617 | $130K |
| Sale | Common Stock | 112 | $26.17 | $3K |
Holdings After Transaction:
Stock Option (Right to Buy) — 119,158 shares (Direct);
Common Stock — 361,621 shares (Direct)
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares of common stock of the Issuer were sold in multiple transactions by the Reporting Person at prices ranging from $24.060 to $25.040, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares of common stock sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares of common stock of the Issuer were sold in multiple transactions by the Reporting Person at prices ranging from $25.060 to $26.045, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares of common stock sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares of common stock of the Issuer were sold in multiple transactions by the Reporting Person at prices ranging from $23.720 to $24.620, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares of common stock sold at each separate price within the range. 50% of the shares subject to the option vested on September 11, 2017 and the remaining 50% vested on September 11, 2019.
FAQ
What did MEG (MEG) disclose in this Form 4?
The President & CEO and Director exercised options and sold common shares on November 10–11, 2025, under a Rule 10b5-1 plan.
How many options did MEG’s CEO exercise and at what price?
He exercised 44,983 options on Nov 10 and 44,984 on Nov 11 at an exercise price of $6.03 per share.
What were the price ranges for the weighted average sales?
Ranges: $24.060–$25.040 (note 1), $25.060–$26.045 (note 2), and $23.720–$24.620 (note 3).
Were these MEG trades under a Rule 10b5-1 plan?
Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan.
What is the vesting detail for the exercised options?
Per note 4, 50% vested on September 11, 2017 and the remaining 50% vested on September 11, 2019.